Crispr Therapeutics AG vs DigitalOcean Holdings Inc — how do they compare? Crispr Therapeutics AG trades at $53.9 (market cap $5.23B), while DigitalOcean Holdings Inc trades at $124 (market cap $14.21B). The key difference: DigitalOcean Holdings Inc is far larger — about 2.7× Crispr Therapeutics AG's market cap, and DigitalOcean Holdings Inc is trading nearer its 52-week high, Crispr Therapeutics AG nearer its low. Which is the better fit depends on your goals.
| CRSP | DOCN | |
|---|---|---|
Market Cap | $5.23B | $14.21B |
Sector | Health | Technology |
52-Week High | $76.78 | $181.29 |
52-Week Low | $44.34 | $29.99 |
Enterprise Value | $3.65B | $14.97B |
Trailing returns across standard periods
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →